TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioteria Technologies AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
140,360
|
107,667
|
90,101 |
| Financial expenses |
2,274
|
1,383
|
164 |
| Earnings before taxes |
-15,856
|
-9,206
|
3,539 |
| EBITDA |
-5,316
|
-854
|
8,249 |
| Total assets |
98,259
|
94,114
|
49,816 |
| Current assets |
40,622
|
35,870
|
38,126 |
| Current liabilities |
59,824
|
65,256
|
28,127 |
| Equity capital |
8,056
|
11,534
|
20,183 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
60
|
63
|
56 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
8.2%
|
12.3%
|
40.5% |
| Turnover per employee |
2,339
|
1,709
|
1,609 |
| Profit as a percentage of turnover |
-11.3%
|
-8.6%
|
3.9% |
| Return on assets (ROA) |
-13.8%
|
-8.3%
|
7.4% |
| Current ratio |
67.9%
|
55.0%
|
135.5% |
| Return on equity (ROE) |
-196.8%
|
-79.8%
|
17.5% |
| Change turnover |
30,751
|
11,173
|
14,164 |
| Change turnover % |
28%
|
12%
|
19% |
| Chg. No. of employees |
-3
|
7
|
15 |
| Chg. No. of employees % |
-5%
|
13%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.